Modelled DT Structure
Method: homology modeling
Template PDB: 6V3F_A
Identity: 76.361%
Minimized Score: -3191.503 kcal/mol
Detail: Structure Info
General Information of DT | |||||
---|---|---|---|---|---|
DT ID | DTD0439 | ||||
Gene Name | SLC65A2 | ||||
Protein Name | Niemann-Pick C1-like protein 1 | ||||
Gene ID | |||||
UniProt ID | |||||
TCDB ID | |||||
3D Structure |
Modelled DT Structure Method: homology modeling Template PDB: 6V3F_A Identity: 76.361% Minimized Score: -3191.503 kcal/mol Detail: Structure Info |
||||
Synonyms | LDLCQ7; NPC1-like intracellular cholesterol transporter 1; NPC11L1; NPC1L1; SLC65A2 | ||||
DT Family | Resistance-Nodulation-Cell Division (RND) Superfamily | ||||
Eukaryotic (Putative) Sterol Transporter (EST) Family | |||||
Function | This transporter is critical for the uptake of cholesterol across the plasma membrane of the intestinal enterocyte. Is the direct molecular target of ezetimibe, a drug that inhibits cholesterol absorption. Lack of activity leads to multiple lipid transport defects. The protein may have a function in the transport of multiple lipids and their homeostasis, and may play a critical role in regulating lipid metabolism. Acts as a negative regulator of NPC2 and down-regulates its expression and secretion by inhibiting its maturation and accelerating its degradation. | ||||
Endogenous Substrate(s) | Lipids | ||||
Variability Data of This Drug Transporter (DT) | |||||
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
(α) Microbiota Influence of This DT |
|||||
(β) Post-translational Modification of This DT |
|||||
(γ) Transcriptional Regulation of This DT |
|||||
(ε) Exogenous Modulation of This DT |
|||||
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
(β) Inter-species Structural Differences |
|||||
(δ) Xenobiotics-regulated Structural Variability |
|||||
General Variability Data of This DT (VARIDT 1.0) |
|||||
(α) Genetic Polymorphisms of This DT |
|||||
(β) Disease-specific Protein Abundances of This DT |
|||||
Molecular Transporting Profile of This DT | |||||
Full List of Drug(s) Transported by This DT |
|||||
Clinical Trial Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
Cholesterol
|
Phase 2 | Drug Info | Cone-Rod dystrophy | 9B70 | [1] |
Endogenous Metabolites (EMs) Handled by This DT |
|||||
Endogenous Metabolites (EMs) |
Click to Show/Hide the Full List of EMs: 1 EMs in Total | ||||
EM Name | PubChem CID | Detail | Experimental Material | Ref | |
Lipoprotein unspecific | N.A. | EM Info | Unclear experiment used for identifying this EM | [2] | |
References | |||||
1 | Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science. 2004 Feb 20;303(5661):1201-4. | ||||
2 | Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 2010 Aug 5;466(7307):707-13. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.